Dynamic Technology Lab Private LTD Cyma Bay Therapeutics, Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$10.86 - $17.62 $298,193 - $483,809	27,458 New	27,458 $409,000
Q3 2022 Nov 14, 2022	BUY	$2.77 - $4.25 $27,960 - $42,899	10,094 New	10,094 $35,000
Q1 2022 May 16, 2022	SELL	$2.77 - $3.64 $30,674 - $40,309	-11,074 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.23 - $4.6 $35,769 - $50,940	11,074 New	11,074 $37,000
Q1 2021 May 14, 2021	SELL	$4.23 - $6.55 $96,486 - $149,405	-22,810 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$5.73 - $9.03 $130,701 - $205,974	22,810 New	22,810 $131,000
Q2 2020 Aug 14, 2020	SELL	$1.41 - $4.25 $24,787 - $74,715	-17,580 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$1.25 - $2.02 $21,975 - $35,511	17,580 New	17,580 $26,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.